BioGeneration Ventures
Venture capital
RollingLast verified 7 Nov 2026
Venture capital firm investing in innovative early-stage life sciences and biotech companies, typically acting as lead investor at the seed stage.
3 deals in the last 24 months, latest 6 Oct 2026. From its website and its deals in the news.
Key facts
- Stages
- Seed, Series A, Series B
- Sectors
- Biotech & pharma
- Typical round size
- €85M (median of its recent deals, not a ticket)
- Leads rounds
- 33% of recent deals with a known role
- Eligible countries
- Not stated
- Provider based in
- Netherlands
- Timing
- Rolling applications
- Focus
- life sciences; early stage biotech
- How to apply
- Apply route unknown
Recent deals
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
We are a venture capital firm specialised in seed investment for innovative early stage companies.
https://biogenerationventures.com/en - Kind
We are a venture capital firm specialised in seed investment for innovative early stage companies.
http://www.biogenerationventures.com/ - Sectors
transform entrepreneurs and their companies to become attractive investment opportunities within the life sciences industry.
https://biogenerationventures.com/en - Sectors
transform entrepreneurs and their companies to become attractive investment opportunities within the life sciences industry.
http://www.biogenerationventures.com/ - Stages
specialised in seed investment for innovative early stage companies.
https://biogenerationventures.com/en - Stages
specialised in seed investment for innovative early stage companies.
http://www.biogenerationventures.com/
Status history
- 7 Nov 2026: Uncertain → Rolling (profiles: investor activity)
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Uncertain → Rolling (page changed)
- 6 Nov 2026: Uncertain (first extraction)
Something wrong or out of date? Report an error.
Work at BioGeneration Ventures? Claim this profile to confirm what you invest in.